AdvanDx's Series B Round

AdvanDx raised a round of funding on May 15, 2006.

AdvanDx is a provider of rapid and accurate molecular diagnostic tests for identification of pathogens that cause critical infections in hospitalized patients. The company's mission is to improve anti…

Articles about AdvanDx's Series B Round: